Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thermavis was a UK-based brand or business unit focused on AI-enabled thermal screening cameras intended to detect elevated skin temperature in workplaces and public settings during the COVID-19 era. Its flagship offering, the Thermavis Multi-Person Thermal Screening Camera, was marketed as a non-intrusive device capable of screening multiple people simultaneously for fever. Public reporting indicates Thermavis was backed by Transputec, a managed IT services provider, rather than operating as a traditional biotech or pharmaceutical company. The business appears to have been positioned at the intersection of workplace safety, health screening, and computer vision rather than therapeutics or drug development. Based on currently available evidence, Thermavis does not appear to be an active standalone life sciences company today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thermavis.